Empowering Informed Family Planning: GenEmbryomics' Whole-Genome Sequencing for Healthier IVF Embryos

GenEmbryomics is the first company in the world to offer a comprehensive whole-genome sequencing screening test for in vitro fertilization (IVF) embryos, providing a novel way to screen for genetic diseases before pregnancy. De novo mutations spontaneously occurring at fertilization account for over 4,525 genetic diseases that are routinely missed by currently used preimplantation genetic testing. To learn more, please visit https://www.redchip.com/stocks/GenEmbryomics/